Camson Bio Technologies has filed four applications on June 14, 2011, under the different categories of bio-pesticidal and bio-weedicidal formulation and a process of preparation thereof with the controller of patents and design.
Last year in November, Camson Bio Technologies had secured its board’s nod to issue further capital of upto Rs 150 crore through QIP / FCCB / GDR / Preferential Allotment / Equity / NCD + warrants issue to promoters and others. The approval was given at its meeting held on November 14, 2010. The approval, however, was subject to the requisite approval of the shareholders.
Camson Bio Technologies operates as an integrated agriculture biotechnology company in India. It produces hybrid seeds, bio-fungicides, bio-insecticides, bio-stimulants, bio-fertilizers, and biocides catering to the requirements of farmers.
| Company Name | CMP |
|---|---|
| Venkys India | 1423.35 |
| Mangalam Global Ent | 15.75 |
| Kaveri Seed | 848.90 |
| Regaal Resources | 77.51 |
| Simran Farms | 164.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: